辰罡科技(08131.HK):聯交所通知開展取消公司的上市地位
格隆匯 3 月 15日丨辰罡科技(08131.HK)發佈公吿,根據函件,基於相關決定,公司須提交復牌建議,以證明其擁有GEM上市規則第17.26條所規定的足夠業務運作及資產水平。倘公司未能提交可行的復牌建議,聯交所將開展取消公司的上市地位。
根據GEM上市規則第4章,公司有權將該決定轉交GEM上市委員會複核。公司可於2021年3月23日或之前要求GEM上市委員會複核該決定。倘公司並無於3月23日前作出任何複核申請,股份將自3月24日上午九時正起暫停買賣。在此的前,股份買賣將會繼續。公司仍在審閲該函件,並正就該函件與公司的法律及財務顧問進行討論,並將積極考慮提出要求將該決定轉交GEM上市委員會進行覆核。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.